Market Prime for Tonalin® CLA

Monheim, Germany—Elizabeth Sloan, Ph.D., president of Sloan Trends Inc., revealed new consumer research and highlighted valuable opportunities for dietary supplements and functional food producers worldwide at SupplySide West in Las Vegas last week.
“The market is prime for conjugated linoleic acid (CLA) to be the new effective tool for healthy aging baby boomers in terms of building muscle strength and improving body composition,” said Dr. Sloan during a 2008 SupplySide West VendorWorks seminar.
Cognis Nutrition & Health, manufacturer of Tonalin®, a brand of CLA and the most clinically studied CLA, sponsored the seminar and recently hosted a webcast event following the announcement FDA issued a “no questions letter” to Cognis’ GRAS notification (GRN 00232). Tonalin CLA achieved GRAS (generally recognized as safe) status and can now be safely used in an expanded range of functional foods and beverages.
Dr. Sloan noted she has been tracking trends for 30 years and has never seen a bigger demand for health driven functional foods. She pointed out the weight management market is at an all-time high in the U.S. and is expected to reach $59 to 60 billion by 2010 (MarketData Enterprises 2007).
“Consumers, particularly those 50 and above, clearly see the benefits of getting rid of body fat, not just getting rid of weight. While dieting is at the lowest level it’s been in 16 years, consumers are hungry for safe, natural alternatives to improve their body composition.”
According to scientific evidence, Tonalin CLA helps consumers reduce body fat up to 9 percent; increase lean muscle mass, which aids in efficient calorie burning; and prevents fat cells from refilling. Tonalin®’s effectiveness has been confirmed by 17 clinical trials published in peer-reviewed journals.

www.Cognis.com